Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Biodexa Pharmaceuticals Plc BDRX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • GB • USD

SharesGrow Score
27/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Analyst Consensus — BDRX

No analyst consensus data available for BDRX.

People Also View

ESLA
ESLA
Estrella Immunopharma, Inc.
$1.73
-1.14%
 KZIA
KZIA
Kazia Therapeutics Limited
$9.46
+5.23%
 BIVI
BIVI
BioVie Inc.
$1.46
+5.80%
 GLMD
GLMD
Galmed Pharmaceuticals Ltd.
$0.71
-6.70%
 GNPX
GNPX
Genprex, Inc.
$1.21
+0.83%
 CANF
CANF
Can-Fite BioPharma Ltd.
$3.05
+4.45%
 CNSP
CNSP
CNS Pharmaceuticals, Inc.
$2.64
+5.18%
 INM
INM
InMed Pharmaceuticals Inc.
$0.71
+0.29%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message